What is RxFul?

Patient-specific compounded medications flow through a defined stack: the prescriber authorizes the order, a platform routes it, a 503A pharmacy compounds it, and a carrier ships it. RxFul occupies the infrastructure layer above the pharmacy — white-label portal UX, partner orchestration, and 3PL logistics — while licensed 503A pharmacies retain dispensing authority. RxFul explicitly states it never appears to dispense; the pharmacy holds the license.

This distinction matters when you evaluate RxFul. Questions about compounding quality, certificates of analysis, and state licensure are about the 503A partners behind the platform. Questions about branding, SaaS tier selection, patient checkout UX, and fulfillment economics are about RxFul itself.

RxFul is not a compounding pharmacy and does not hold pharmacy licensure. It connects clinics to licensed 503A partners and coordinates 3PL fulfillment. It is also not an electronic medical record — RxFul handles patient-facing pharmacy infrastructure, not charting, scheduling, or clinical documentation.

RxFul is also not a prescriber-first batch ordering dashboard. Fizy Health operates at the clinic staff layer: one cart for every patient on refill day, pass-through per-vial 503A cost visible before checkout, and validation before payment. The two solve adjacent problems — patient brand infrastructure versus prescriber ops — and clinics sometimes evaluate both.